Financials Biocept, Inc.

Equities

BIOCQ

US09072V6002

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 03:02:01 2024-04-23 pm EDT 5-day change 1st Jan Change
0.0001 USD 0.00% Intraday chart for Biocept, Inc. 0.00% -99.76%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 24.41 3.493 12.07 59.48 60.97 9.041
Enterprise Value (EV) 1 25.05 1.696 5.313 57.34 44.78 8.253
P/E ratio - - -0.23 x -2.95 x -18.9 x -0.28 x
Yield - - - - - -
Capitalization / Revenue 4.82 x 1.07 x 2.18 x 2.17 x 1 x 0.35 x
EV / Revenue 4.94 x 0.52 x 0.96 x 2.09 x 0.73 x 0.32 x
EV / EBITDA -1.22 x -0.07 x -0.24 x -3.99 x -50.9 x -0.27 x
EV / FCF -1.9 x -0.12 x -0.34 x -3.89 x 22.7 x -0.89 x
FCF Yield -52.5% -802% -291% -25.7% 4.4% -112%
Price to Book - 1.31 x 1.4 x 2.51 x 1.63 x 1.02 x
Nbr of stocks (in thousands) 3.91 13.5 141 447 561 569
Reference price 2 6,245 258.0 85.80 133.2 108.6 15.90
Announcement Date 3/28/18 3/29/19 3/27/20 3/31/21 4/5/22 4/17/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 5.069 3.25 5.529 27.46 61.25 25.86
EBITDA 1 -20.6 -23.46 -22.13 -14.38 -0.879 -30.33
EBIT 1 -21.17 -24.26 -23.06 -15.47 -2.409 -31.98
Operating Margin -417.76% -746.35% -417.05% -56.33% -3.93% -123.69%
Earnings before Tax (EBT) 1 -21.61 -24.57 -25.14 -17.81 -2.699 -32.21
Net income 1 -21.61 -24.57 -25.14 -17.81 -2.824 -32.09
Net margin -426.42% -755.98% -454.69% -64.84% -4.61% -124.09%
EPS - - -366.8 -45.11 -5.734 -56.78
Free Cash Flow 1 -13.16 -13.61 -15.48 -14.75 1.971 -9.222
FCF margin -259.58% -418.73% -280.01% -53.72% 3.22% -35.66%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/28/18 3/29/19 3/27/20 3/31/21 4/5/22 4/17/23
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales 1 - 12.05 17.47 13.93 19.94 10.61 5.587 -10.28 0.673 0.589
EBITDA - - - - - - - - - -
EBIT - -1.748 0.5016 -2.776 -2.707 -5.097 -5.577 -18.6 - -
Operating Margin - -14.51% 2.87% -19.93% -13.57% -48.04% -99.82% 180.88% - -
Earnings before Tax (EBT) - -1.827 0.427 -2.846 -2.768 -5.252 -5.545 -18.65 - -
Net income 2.599 -1.827 0.427 -2.971 -2.768 -5.252 -5.545 -18.52 - -
Net margin - -15.17% 2.44% -21.33% -13.88% -49.5% -99.25% 180.09% - -
EPS 5.700 -15.30 0.9000 -5.400 -4.800 -9.300 -9.900 -32.70 - -
Dividend per Share - - - - - - - - - -
Announcement Date 5/12/21 8/16/21 11/15/21 4/6/22 5/23/22 11/10/22 11/21/22 4/17/23 5/10/23 8/14/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 0.64 - - - - -
Net Cash position 1 - 1.8 6.76 2.14 16.2 0.79
Leverage (Debt/EBITDA) -0.0312 x - - - - -
Free Cash Flow 1 -13.2 -13.6 -15.5 -14.8 1.97 -9.22
ROE (net income / shareholders' equity) -2,211% -1,133% -353% -102% -9.23% -138%
ROA (Net income/ Total Assets) -177% -188% -109% -29.7% -2.79% -43.8%
Assets 1 12.21 13.07 23.1 60.03 101.2 73.27
Book Value Per Share - 197.0 61.40 53.10 66.70 15.60
Cash Flow per Share - 222.0 51.00 32.20 51.40 22.70
Capex 1 1.4 0.15 0.74 0.87 1.57 0.81
Capex / Sales 27.62% 4.47% 13.3% 3.16% 2.57% 3.12%
Announcement Date 3/28/18 3/29/19 3/27/20 3/31/21 4/5/22 4/17/23
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.0001
Average target price
-
Consensus
  1. Stock Market
  2. Equities
  3. BIOCQ Stock
  4. Financials Biocept, Inc.